Skip to content

Carisma Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2021

    CARISMA Therapeutics appoints Richard Morris CFO

    CARISMA Therapeutics announced that Richard Morris had been appointed chief financial officer.

  2. 2021

    CARISMA Therapeutics completes $47 million Series B financing

    CARISMA Therapeutics completed a Series B equity financing that provided gross proceeds of $47 million.